INVESTOR NOTICE: Rosen Law Firm Reminds Eros International

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
INVESTOR NOTICE: Rosen Law Firm Reminds Eros International Plc Investors of Important January 12, 2016 Deadline in Class Action – EROS

NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Eros International Plc (NYSE: EROS ) securities from June 17, 2014 through October 30, 2015, both dates inclusive (the “Class Period”) of the important January 12, 2016 lead plaintiff deadline. The lawsuit seeks to recover damages for Eros investors under the federal securities laws.

To join the Eros class action, go to the firm’s website at http://rosenlegal.com/cases-770.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com  or kchan@rosenlegal.com  for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period, Defendants issued materially false and misleading statements to investors and/or failed to disclose that: (i) Eros’ reported earnings significantly overstated the economic viability of Eros’s business model; (ii) Eros’ accounting policy for amortization was unjustifiably aggressive in light of the impact of piracy on the long-term value of Eros’s assets; (iii) despite Eros’ reported profitability, Eros generates no cash; (iv) Eros has only been able to stay afloat by issuing stock and taking on debt; (v) Eros significantly overstated the number of Eros distributed and Eros’ theatrical revenues during fiscal years 2014 and 2015; and (vi) as a result of the foregoing, Eros’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-770.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com  or kchan@rosenlegal.com .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.

 

Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY  10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 66

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 239

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 187

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Bull Market Optimism Fueled by AI Growth After TSMC Results

Updated Category News Views 239

Insights on AI Market Dynamics and TSMC's Performance In a recent discussion, Gene Munster provided his perspective on the burgeoning AI market landscape, particularly highlighting the recent performance of Taiwan Semiconductor Manufacturing Company Ltd (NASDAQ: TSM). After TSMC reported promising third-quarter results, Munster emphasized the need for investors to...

Continue Reading
Understanding Mueller Industries Inc's Earnings Performance

Updated Category News Views 216

Current Market Performance of Mueller Industries Inc Mueller Industries Inc. (NYSE: MLI) is currently trading at $81.46, marking a slight increase of 0.74% in its latest session. This upward trajectory indicates a positive trend as the stock saw an increase of 0.73% in the past month and an impressive 57.50% in the past year. These figures present a favorable outlook for...

Continue Reading
RayNeo and Bang & Olufsen Join Forces for New Audio Experience

Updated Category News Views 179

RayNeo Partners with Bang & Olufsen for Enhanced AR Experience RayNeo, a recognized leader in augmented reality eyewear, has taken an exciting step forward by announcing a significant strategic licensing partnership with Bang & Olufsen. This collaboration aims to infuse ‘Audio by Bang & Olufsen’ into RayNeo’s upcoming AR glasses, offering users a truly immersive...

Continue Reading
Understanding AI's Impact on Energy by Schneider Electric

Updated Category News Views 147

AI and Energy Management Insights from Schneider Electric Schneider Electric, a leader in digital energy management and automation, has recently unveiled two integral research reports shedding light on the intersection of artificial intelligence (AI) and energy consumption. These comprehensive studies address pressing concerns regarding the sustainability of energy usage...

Continue Reading
Oil Prices Maintain Stability Amid Ceasefire Discussions and OPEC+ Meeting

Updated Category News Views 183

Current Trends in Oil Prices In recent trading, oil prices appear to have steadied, reflecting a moment of cautious optimism among market participants. With a ceasefire deal between Israel and Hezbollah having been approved, traders are weighing what this might mean for global oil supplies and prices. The anticipated decisions at the upcoming OPEC+ meeting also play a...

Continue Reading